GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » FCF Margin %

Genenta Science SPA (Genenta Science SPA) FCF Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genenta Science SPA's Free Cash Flow for the six months ended in Dec. 2023 was $-3.95 Mil. Genenta Science SPA's Revenue for the six months ended in Dec. 2023 was $0.00 Mil. Therefore, Genenta Science SPA's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Genenta Science SPA's current FCF Yield % is -22.09%.

The historical rank and industry rank for Genenta Science SPA's FCF Margin % or its related term are showing as below:


GNTA's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -143.92
* Ranked among companies with meaningful FCF Margin % only.


Genenta Science SPA FCF Margin % Historical Data

The historical data trend for Genenta Science SPA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA FCF Margin % Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
- - - - -

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Genenta Science SPA's FCF Margin %

For the Biotechnology subindustry, Genenta Science SPA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genenta Science SPA's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's FCF Margin % falls into.



Genenta Science SPA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Genenta Science SPA's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-12.234/0
= %

Genenta Science SPA's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-3.954/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genenta Science SPA FCF Margin % Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genenta Science SPA (Genenta Science SPA) Business Description

Traded in Other Exchanges
Address
Via Olgettina No. 58, Milan, ITA, 20132
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.